Estrogen deficiency accelerates aging of the optic nerve

Menopause

Volumn 19, Issue 8, 2012, Pages 942-947

  Vajaranant, Thasarat S ^a   Pasquale, Louis R ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

AGING; BLINDNESS; CORNEA THICKNESS; ESTROGEN DEFICIENCY; GLIA CELL; HUMAN; INTRAOCULAR PRESSURE; NERVE DEGENERATION; NERVE FIBER; OPEN ANGLE GLAUCOMA; OPTIC NERVE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; RETINA GANGLION CELL; REVIEW; SEX DIFFERENCE; UNITED STATES; VISUAL IMPAIRMENT;

AGING; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GLAUCOMA; HUMANS; MENOPAUSE; OPTIC NERVE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS;

EID: 84864288961     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182443137     Document Type: Review

References (76)

1. Dolman CL, McCormick AQ, Drance SM. Aging of the optic nerve. Arch Ophthalmol 1980;98:2053-2058.
2. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989;107:453-464.
3. Harwerth RS, Wheat JL, Rangaswamy NV. Age-related losses of retinal ganglion cells and axons. Invest Ophthalmol Vis Sci 2008;49:4437-4443.
4. Budenz DL, Anderson DR, Varma R, et al. Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophthalmology 2007;114:1046-1052.
5. Sung KR, Wollstein G, Bilonick RA, et al. Effects of age on optical coherence tomography measurements of healthy retinal nerve fiber layer, macula, and optic nerve head. Ophthalmology 2009;116:1119-1124.
6. Weinreb RN, Khaw PT. Primary open-angle glaucoma [review]. Lancet 2004;363:1711-1720.
7. Tezel G, Luo C, Yang X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci 2007;48: 1201-1211.
8. See JL, Nicolela MT, Chauhan BC. Rates of neuroretinal rim and peripapillary atrophy area change: a comparative study of glaucoma patients and normal controls. Ophthalmology 2009;116:840-847.
9. Gupta N, Yücel YH. Glaucoma as a neurodegenerative disease [review]. Curr Opin Ophthalmol 2007;18:110-114.
10. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-267.
11. Vajaranant TS, Nayak S, Wilensky JT, Joslin CE. Gender and glaucoma: what we know and what we need to know [review]. Curr Opin Ophthalmol 2010;21:91-99.
12. Vajaranant TS, Wu S, Torres M, Varma R, et al. The changing face of primary open-angle glaucoma in the United States: demographic and geographic changes from 2010-2050. Paper presented at: The 21st Annual AGS Meeting, Dana Point, CA, 2011.
13. Central Intelligence Agency. Country comparison: life expectancy at birth. In: World Factbook [Internet]. Langley, VA: CIA; 2010. Available at: https://www.cia.gov/library/publications/the-world-factbook/rankorder/2102rank. html. Accessed November 04, 2011.
14. Austad SN. Why women live longer than men: sex differences in longevity. Gend Med 2006;3:79-92.
15. Mascitelli L, Pezzetta F, Sullivan JL. Why women live longer than men: sex differences in longevity. Gend Med 2006;3:341; author reply 342.
16. Saccà SC, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress [review]. Exp Eye Res 2007;84:389-399.
17. Ryskulova A, Turczyn K,Makuc DM, Cotch MF, Klein RJ, Janiszewski R. Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 National Health Interview Survey. Am J Public Health 2008;98:454-461.
18. National Eye Institute, Healthy Vision 2010 Archive. National Institutes of Health, Department of Health and Human Services. Available at: http://www.nei.nih.gov/healthyvision/. Accessed November 04, 2011.
19. Abou-Gareeb I, Lewallen S, Bassett K, Courtright P. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic Epidemiol 2001;8:39-56.
20. Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Variations in treatment among adult-onset open-angle glaucoma patients. Ophthalmology 2005;112:1494-1499.
21. Harris A, Rechtman E, Siesky B, Jonescu-Cuypers C, McCranor L, Garzozi HJ. The role of optic nerve blood flow in the pathogenesis of glaucoma [review]. Ophthalmol Clin North Am 2005;18:345-353.
22. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology 2008;115:246-252.
23. Johnson EC, Morrison JC. Friend or foe? Resolving the impact of glial responses in glaucoma. J Glaucoma 2009;18:341-353.
24. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States [published correction appears in Arch Opthalmol 2011;129:1224]. Arch Ophthalmol 2004;122:532-538.
25. Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a populationbased study in the Netherlands. The Rotterdam Study. Ophthalmology 1994;101:1851-1855.
26. Guedes G, Tsai JC, Loewen NA. Glaucoma and aging. Curr Aging Sci 2011;4:110-117.
27. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992;99:1499-1504.
28. Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008;115:85-93.
29. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-1669.
30. Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci 2006;47:4254-4261.
31. Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 2004;111:1439-1448.
32. Wensor MD, McCarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998;105:733-739.
33. Albon J, Purslow PP, Karwatowski WS, Easty DL. Age related compliance of the lamina cribrosa in human eyes. Br J Ophthalmol 2000;84: 318-323.
34. Burgoyne CF. A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res 2011;93:120-132.
35. Hernandez MR, Luo XX, Andrzejewska W, Neufeld AH. Age-related changes in the extracellular matrix of the human optic nerve head. Am J Ophthalmol 1989;107:476-484.
36. Harris A, Harris M, Biller J, et al. Aging affects the retrobulbar circulation differently in women and men. Arch Ophthalmol 2000;118: 1076-1080.
37. Altintas O, Caglar Y, Yüksel N, Demirci A, Karabaz L. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004;218:120-129.
38. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999;40:1906-1911.
39. Phillips CI, Gore SM. Ocular hypotensive effect of late pregnancy with and without high blood pressure. Br J Ophthalmol 1985;69:117-119.
40. Qureshi IA, Xi XR, Wu XD. Intraocular pressure trends in pregnancy and in the third trimester hypertensive patients. Acta Obstet Gynecol Scand 1996;75:816-819.
41. Qureshi IA. Intraocular pressure: association with menstrual cycle, pregnancy and menopause in apparently healthy women [published correction appears in Chin J Physiol 1996;39:63]. Chin J Physiol 1995;38:229-234.
42. Green K, Phillips CI, Cheeks L, Slagle T. Aqueous humor flow rate and intraocular pressure during and after pregnancy. Ophthalmic Res 1988; 20:353-357.
43. Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol 1988;105:258-260.
44. Sator MO, Akramian J, Joura EA, et al. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas 1998;29:93-95.
45. Sator MO, Joura EA, Frigo P, et al. Hormone replacement therapy and intraocular pressure. Maturitas 1997;28:55-58.
46. Tint NL, Alexander P, Tint KM, Vasileiadis GT, Yeung AM, Azuara- Blanco A. Hormone therapy and intraocular pressure in nonglaucomatous eyes. Menopause 2010;17:157-160.
47. Toker E, Yenice O, Temel A. Influence of serum levels of sex hormones on intraocular pressure in menopausal women. J Glaucoma 2003;12:436-440.
48. Kang JH, Wiggs JL, Rosner BA, et al. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use. Invest Ophthalmol Vis Sci 2010;51: 971-979.
49. Ohmichi M, Kanda Y, Hisamoto K, et al. Rapid changes of flow-mediated dilatation after surgical menopause. Maturitas 2003;44:125-131.
50. Deschênes MC, Descovich D, Moreau M, et al. Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 2010;51:2587-2600.
51. Harris-Yitzhak M, Harris A, Ben-Refael Z, Zarfati D, Garzozi HJ, Martin BJ. Estrogen-replacement therapy: effects on retrobulbar hemodynamics. Am J Ophthalmol 2000;129:623-628.
52. Atalay E, Karaali K, Akar M, et al. Early impact of hormone replacement therapy on vascular hemodynamics detected via ocular colour Doppler analysis. Maturitas 2005;50:282-288.
53. Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, De Aloysio D. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 2004;11:69-77.
54. Atilla H, Arslanpençe A, Batioǧlu F, et al. Effect of hormone replacement therapy on ocular hemodynamics in postmenopausal women. Eur J Ophthalmol 2001;11:277-280.
55. Akar Y, Yucel I, Akar ME, Taskin O, Ozer HO. Menstrual cycledependent changes in visual field analysis of healthy women. Ophthalmologica 2005;219:30-35.
56. Russo R, Cavaliere F, Watanabe C, et al. 17A-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res 2008;173:583-590.
57. Zhou X, Li F, Ge J, et al. Retinal ganglion cell protection by 17-A-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol 2007;67:603-616.
58. Hulsman CA, Westendorp IC, Ramrattan RS, et al. Is open-angle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 2001;154:138-144.
59. Nirmalan PK, Katz J, Robin AL, et al. Female reproductive factors and eye disease in a rural South Indian population: the Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 2004;45:4273-4276.
60. Pasquale LR, Kang JH. Female reproductive factors and primary open-angle glaucoma in the Nurses' Health Study. Eye (Lond) 2011;25: 633-641.
61. Lee AJ, Mitchell P, Rochtchina E, Healey PR; Blue Mountains Eye Study. Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study. Br J Ophthalmol 2003;87:1324-1328.
62. Pasquale LR, Rosner BA, Hankinson SE, Kang JH. Attributes of female reproductive aging and their relation to primary open-angle glaucoma: a prospective study. J Glaucoma 2007;16:598-605.
63. Doshi V, Ying-Lai M, Azen SP, Varma R. Los Angeles Latino Eye Study Group. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension. The Los Angeles Latino Eye Study. Ophthalmology 2008;115:639-647.
64. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103-115.
65. Miro F, Parker SW, Aspinall LJ, Coley J, Perry PW, Ellis JE. Sequential classification of endocrine stages during reproductive aging in women: the FREEDOM study. Menopause 2005;12:281-290.
66. The North American Menopause Society. Menopause Practice: A Clinician's Guide. Mayfield Heights, OH: The North American Menopause Society, 2010.
67. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review [review]. Fertil Steril 1987;47:94-100.
68. de Voogd S, Wolfs RC, Jansonius NM, et al. Estrogen receptors β and A and the risk of open-angle glaucoma: the Rotterdam Study. Arch Ophthalmol 2008;126:110-114.
69. Mabuchi F, Sakurada Y, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. Estrogen receptor beta gene polymorphism and intraocular pressure elevation in female patients with primary open-angle glaucoma. Am J Ophthalmol 2010;149:826-830.
70. Nakayama M, Yasue H, Yoshimura M, et al. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999;99:2864-2870.
71. Miyamoto Y, Saito Y, Nakayama M, et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786TYC mutation associated with coronary spastic angina. Hum Mol Genet 2000;9:2629-2637.
72. Thorleifsson G, Walters GB, Hewitt AW, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 2010;42:906-909.
73. Wiggs JL, Hee Kang J, Yaspan BL, et al; for the GENEVA Consortium. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum Mol Genet 2011.
74. Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 2010;62:155-198.
75. Miller VM. Sex-based differences in vascular function [review]. Womens Health (Lond Engl) 2010;6:737-752.
76. Luczak ED, Leinwand LA. Sex-based cardiac physiology [review]. Annu Rev Physiol 2009;71:1-18.